All Active Grants
471 grantsAHRQ Conference Grant Programs (R13)
The Agency for Healthcare Research and Quality (AHRQ) announces its interest in supporting conferences through the AHRQ Single-Year and Multiple-Year
Clinical Observational (CO) Studies in Musculoskeletal, Rheumatic, and Skin Diseases (R01 Clinical Trial Not Allowed)
This Clinical Observational (CO) Studies in Musculoskeletal, Rheumatic, and Skin Diseases (R01 Clinical Trial Not Allowed) PAR, was re-issued as a res
Exploratory Clinical Trial Grants in Arthritis and Musculoskeletal and Skin Diseases (R61 Clinical Trial Required)
This Exploratory Clinical Trial Grants in Arthritis and Musculoskeletal and Skin Diseases (R61 Clinical Trial Required) PAR, a re-issue of PAR-24-035,
Developing novel theory and methods for understanding the genetic architecture of complex human traits (R01 Clinical Trial Not Allowed)
The goal of this NOFO is to support applications for novel theory and methods development that enable better understanding of how genetic and non-gene
NCCIH Natural Product Mid Phase Clinical Trial (R01 Clinical Trial Required)
This Notice of Funding Opportunity (NOFO) encourages applications for investigator-initiated mid-phase clinical trials of natural products(i.e., botan
NIDA Mentored Clinical Scientist Development Program Award in Substance Use and Substance Use Disorder Research (K12 Clinical Trial Optional)
This funding opportunity announcement (FOA) encourages applications for institutional research career development (K12) programs that propose to suppo
NCCIH Natural Product Early Phase Clinical Trial Award (R33 Clinical Trial Required)
This Notice of Funding Opportunity (NOFO) encourages applications for investigator-initiated, early phase, clinical trials of natural products (i.e.,
NCCIH Natural Product Early Phase Clinical Trial Phased Innovation Award (R61/R33 Clinical Trial Required)
This Notice of Funding Opportunity (NOFO) encourages applications for investigator-initiated, early phase, clinical trials of natural products (i.e.,
Ethical, Legal and Social Implications (ELSI) Small Research Grant (R03 Clinical Trial Optional)
The purpose of this Notice of Funding Opportunity (NOFO) is to invite Small Research Grant (R21) applications that propose to study the ethical, legal
Feasibility Clinical Trials of Mind and Body Interventions for NCCIH High Priority Research Topics (R34 Clinical Trial Required)
The goal of this notice of funding opportunity (NOFO) is to support feasibility trials of complementary and integrative health approaches with physica
Prevention and Intervention Approaches for Fetal Alcohol Spectrum Disorders (R61/R33 Clinical Trial Optional)
This Notice of Funding Opportunity (NOFO) focuses on prevention and intervention strategies for fetal alcohol spectrum disorders (FASD) throughout the
Investigator Initiated Clinical Trials of Complementary and Integrative Interventions Delivered Remotely or via mHealth (R01 Clinical Trial Required)
This Notice of Funding Opportunity (NOFO) encourages applications for investigator-initiated fully remotely delivered and conducted clinical trials to
NCCIH Multi-Site Feasibility Clinical Trials of Mind and Body Interventions (R01 Clinical Trial Required)
This notice of funding opportunity (NOFO) invites applications for investigator-initiated clinical trials of complementary and integrative health appr
Ethical, Legal and Social Implications (ELSI) Research (R01 Clinical Trial Optional)
The purpose of this NOFO is to invite Research Project (R01) applications that propose to study the ethical, legal, and social implications (ELSI) of
Ethical, Legal and Social Implications (ELSI) Exploratory/Developmental Research Grant (R21 Clinical Trial Optional)
The purpose of this NOFO is to invite Exploratory/Developmental Research Grant (R21) applications that propose to study the ethical, legal, and social
NIH StrokeNet Clinical Trials and Biomarker Studies for Stroke Treatment, Recovery, and Prevention (UG3/UH3 Clinical Trial Optional)
This NOFO encourages applications for multi-site exploratory and confirmatory clinical trials focused on promising interventions; biomarker or outcome
Seamless Early-Stage Clinical Drug Development (Phase 1 to 2a) for Novel therapeutic Agents for the Spectrum of Alzheimer's Disease (AD) and AD-related Dementias (ADRD) (UG3/UH3 Clinical Trial Required)
The purpose of this Notice of Funding Opportunity (NOFO) is to invite applications that bundle independent protocols for phase 1 clinical trials with
HEAL Initiative: Pain Research Enhancement Program (PREP) (R15 Clinical Trial Optional)
The purpose of this initiative is to: (1) support the efforts by R15-eligible Principal Investigators (PIs) to conduct rigorous basic and/or mechanist
Competing Revisions to Existing NIH Single Project Research Grants and Cooperative Agreements (Clinical Trial Optional)
The National Institutes of Health (NIH) hereby notifies NIH award recipients that funds may be available for revision applications to support the expa
National Center for Construction Safety and Health Research and Translation (U54)
NIOSH is encouraging the submission of an application from qualified organizations for a National Center for Construction Safety and Health Research a
Emerging Global Leader Award (K43 Independent Clinical Trial Required)
This is a reissue of the Emerging Global Leader Program (K43) to align with the clinical trials policy.
Emerging Global Leader Award (K43 Independent Clinical Trial Not Allowed)
This Funding Opportunity Announcement (FOA) is designed specifically for applicants proposing research that does not involve leading an independent cl
NIH Research Software Engineer (RSE) Award (R50 Clinical Trials Not Allowed)
The purpose of this notice of funding opportunity (NOFO) is to provide salary support for exceptional Research Software Engineers (RSEs) that contribu
Intervention Research to Improve Native American Health (R34 Clinical Trial Optional)
The purpose of this notice of funding opportunity (NOFO) is to support research on interventions to improve health in Native American (NA) populations
Intervention Research to Improve Native American Health (R01 Clinical Trial Optional)
Not available